RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.

FAQ

What is the symbol for Aerie Pharmaceuticals Stock and on which exchange is it traded?
The symbol for Aerie Pharmaceuticals is AERI and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Aerie Pharmaceuticals Stock?
Aerie Pharmaceuticals holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Aerie Pharmaceuticals Stock?
Aerie Pharmaceuticals Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Aerie Pharmaceuticals Stock.

What's the current price of Aerie Pharmaceuticals Stock?
As of the end of day on the 2023-02-17, the price of an Aerie Pharmaceuticals (AERI) share was $15.25.

What is the 52-week high and low for Aerie Pharmaceuticals Stock?
The 52-week high for Aerie Pharmaceuticals Stock is $15.37 and the 52-week low is $4.81.
Click to get the best stock tips daily for free!

About Aerie Pharmaceuticals

Aerie Pharmaceuticals Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension; and Rocklatan, a once-daily ... AERI Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT